Revvity partners with Sanofi to develop type 1 diabetes screening test
Go back to Revvity partners with Sanofi to develop type 1 diabetes screening test| (NYSE: RVTY) | Delayed: 124.13 +4.68 (3.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $119.45 | 52 Week High | $ | |||
| Open | $118.26 | 52 Week Low | $ | |||
| Day High | $124.49 | P/E | N/A | |||
| Day Low | $116.96 | EPS | $ | |||
| Volume | 2,344,490 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 45.15 -0.68 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.83 | 52 Week High | $44.76 | |||
| Open | $45.65 | 52 Week Low | $36.81 | |||
| Day High | $45.74 | P/E | N/A | |||
| Day Low | $45.06 | EPS | $0.00 | |||
| Volume | 2,598,247 | |||||

